-
Mashup Score: 5People who mostly sit at work have a 16% higher risk of mortality, study says | CNN - 3 month(s) ago
Just a little light physical activity during work can improve health. Here’s how to incorporate “exercise snacks” and improve your health, even if you’re desk-bound.
Source: us.cnn.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 13Hyperbaric oxygen therapy for the treatment of perianal fistulas in 20 patients with Crohn's disease: Results of the HOT‐TOPIC trial after 1‐year follow‐up - 10 month(s) ago
Previously published short‐term results (week 16) of this trial showed a significant improvement in clinical, radiologic and biochemical outcomes in Crohn’s disease patients with therapy‐refractory perianal fistulas after treatment with …
Source: www.ncbi.nlm.nih.govCategories: Gastroenterology, Latest HeadlinesTweet
-
Mashup Score: 2Ileocecal resection may have role as ‘primary treatment’ in recently diagnosed Crohn’s - 1 year(s) ago
CHICAGO — Patients who underwent ileocecal resection for Crohn’s disease had a 33% lower risk for hospitalization, repeat surgery, systemic corticosteroid exposure and perianal CD, according to a presenter at Digestive Disease Week. “The LIR!C trial has demonstrated comparable quality of life with ileocecal resection compared to infliximab as a first-line treatment for limited,
Source: www.healio.comCategories: Gastroenterology, Latest HeadlinesTweet
-
Mashup Score: 1High-dimensional profiling reveals Tc17 cell enrichment in active Crohn’s disease and identifies a potentially targetable signature - 2 year(s) ago
The immune-pathology in Crohn’s disease is linked to dysregulated CD4+ T cell responses biased towards pathogenic TH17 cells. However, the role of CD8+ T cells able to produce IL-17 (Tc17 cells) remains unclear. Here we characterize …
Source: PubMed Central (PMC)Categories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 0CD sales grow for first time since 2004 - 2 year(s) ago
2021 CD sales were up more than $100 million from 2020.
Source: AxiosCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 5Crohn's & Colitis Foundation - 2 year(s) ago
Crohn’s & Colitis Foundation
Categories: Gastroenterology, Latest HeadlinesTweet
-
Mashup Score: 3CD exclusion diet induces, maintains remission in Crohn’s - 2 year(s) ago
The Crohn’s disease exclusion diet with or without enteral nutrition induced and maintained remission in adult patients with mild to moderate CD and may lead to full endoscopic remission. “The current goal of medical therapy is to reduce inflammation and induce mucosal healing, which can be achieved by modifying immune pathways; however, many of the drugs used to manage Crohn’s
Source: www.healio.comCategories: Gastroenterology, Latest HeadlinesTweet
-
Mashup Score: 10Contemporary Risk of Surgery in Patients With Ulcerative Colitis and Crohn’s Disease: A Meta-Analysis of Population-Based Cohorts - 3 year(s) ago
We conducted a systematic review with meta-analysis to estimate rates and trends of colectomy in patients with ulcerative colitis (UC), and of primary and re-resection in patients with Crohn’s disease (CD), focusing on contemporary risks.
Categories: Gastroenterology, Latest HeadlinesTweet
-
Mashup Score: 3High-Dose Vitamin D Does Not Prevent Postoperative Recurrence of Crohn’s Disease in a Randomized Placebo-Controlled Trial - 3 year(s) ago
Vitamin D deficiency is common in Crohn’s disease (CD). High-dose vitamin D had anti-inflammatory effects in preclinical studies and trials of patients with CD. We performed a randomized trial to determine whether high-dose vitamin D prevents postoperative recurrence of CD after ileocolonic resection.
Categories: Gastroenterology, Latest HeadlinesTweet
-
Mashup Score: 0VIDEO: Stelara, Humira safely, effectively treat CD - 3 year(s) ago
Stelara and Humira demonstrated rapid onset of action and effectiveness in the treatment of patients with moderate to severe Crohn’s disease, Bruce Sands, MD, Icahn School of Medicine, told Healio Gastroenterology. In a multicenter, blinded, active-controlled study, researchers randomly assigned 386 biologic-naive patients 1:1 to receive either Stelara (ustekinumab, Janssen) or Humira
Source: www.healio.comCategories: Gastroenterology, Latest HeadlinesTweet
Tired of sitting at a desk all day long? Turns out it’s not good for your health, either. People who predominantly sit at work have a 16% higher risk of mortality from all causes & a 34% higher risk of mortality from #CD. Learn more @JAMANetworkOpen. https://t.co/ZjhPhLb3mC